All stocks Β· AKUMS
AD

Akums Drugs and Pharmaceuticals Limited

AKUMS BSE Drug Manufacturers - Specialty & Generic Healthcare

Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, nutraceuticals, food and die…

ISIN INE09XN01023
Listed β€”
Quarters tracked 13
Filings 7 docs

About

Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offers branded formulations on various dosage forms, including tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form-fill-seal products, topical preparations, eye drops, dry powder injections, and gummies for therapeutic areas, such as antiinfectives, pain management, gastroenterology, orthopaedics, cardio-diabetic care, critical care, respiratory, and gynaecology. In addition, the company operates as pharmaceutical contract development and manufacturing company. Akums Drugs and Pharmaceuticals Limited was incorporated in 2004 and is based in Delhi, India.

Key Metrics

as of Sep 2026
Market Cap12,052 Cr
P/E39.50
Div Yield0.13 %
Book Valueβ‚Ή211.00
52w Highβ‚Ή797.00
52w Lowβ‚Ή409.00
Face Valueβ‚Ή2.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 392.00 338.00 369.00 309.00 332.00 329.00 337.00 328.00 317.00 298.00 383.00 447.00 316.00
Expenses 344.00 327.00 344.00 292.00 288.00 311.00 303.00 285.00 274.00 359.00 351.00 358.00 503.00
Operating Profit 49.00 12.00 25.00 17.00 44.00 18.00 34.00 43.00 44.00 -61.00 32.00 89.00 -187.00
OPM % 12.00 3.50 7.00 5.00 13.00 5.00 10.00 13.00 14.00 -20.00 8.00 20.00 -59.00
Other Income 26.00 25.00 26.00 27.00 29.00 32.00 34.00 32.00 26.00 25.00 25.00 4.00 20.00
Depreciation 13.00 12.00 12.00 11.00 10.00 10.00 11.00 9.00 9.00 9.00 8.00 8.00 7.00
Interest 2.00 3.00 2.00 2.00 3.00 3.00 2.00 4.00 6.00 5.00 5.00 5.00 4.00
Profit before tax 59.00 22.00 36.00 31.00 60.00 37.00 55.00 62.00 54.00 -49.00 43.00 81.00 -178.00
Tax % 24.00 30.00 22.00 25.00 25.00 26.00 25.00 18.00 23.00 18.00 32.00 35.00 6.00
Net Profit 45.00 15.00 28.00 23.00 45.00 28.00 41.00 50.00 42.00 -58.00 29.00 53.00 -190.00
EPS in Rs 2.85 0.97 1.79 1.49 2.85 1.75 2.62 3.20 2.84 -4.05 2.05 3.69 -13.26

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Sales 1,349.001,312.001,444.001,287.001,162.00837.00737.00683.00596.00
Expenses 1,251.001,173.001,570.001,045.001,524.00811.00697.00603.00521.00
Operating Profit 98.00139.00-126.00242.00-362.0027.0040.0080.0075.00
OPM % 7.0011.00-9.0019.00-31.003.205.0012.0013.00
Other Income 106.00124.0074.00-48.0058.00-195.0066.0058.0055.00
Interest 10.0015.0018.0013.004.001.004.004.003.00
Depreciation 46.0040.0033.0030.0028.0026.0025.0023.0023.00
Profit before tax 148.00208.00-103.00150.00-335.00-195.0076.00112.00105.00
Tax % 25.0023.0061.0017.0014.00-26.0033.0033.0035.00
Net Profit 112.00161.00-165.00125.00-382.00-145.0051.0075.0068.00
EPS in Rs 7.0910.23-11.568.77-53.37-1,118.18391.05636.94576.34
Dividend Payout % 41.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Equity Capital 31.0031.0029.0029.0014.001.001.001.001.00
Reserves 2,397.002,275.00115.00283.00171.00566.00711.00841.00766.00
Borrowings 59.0046.00267.00146.00140.0041.0036.0051.0033.00
Other Liabilities 326.00333.001,684.001,437.001,488.00690.00678.00153.00160.00
Total Liabilities 2,812.002,685.002,095.001,894.001,814.001,298.001,426.001,046.00960.00
Fixed Assets 425.00356.00317.00272.00253.00244.00242.00237.00236.00
CWIP 52.0057.009.0016.001.001.001.000.000.00
Investments 366.00366.00139.00139.00141.00149.0065.004.004.00
Other Assets 1,969.001,906.001,631.001,466.001,419.00903.001,118.00806.00720.00
Total Assets 2,812.002,685.002,095.001,894.001,814.001,298.001,426.001,046.00960.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Cash from Operating Activity -2.0091.00248.0094.00228.0056.00-22.00
Cash from Investing Activity -25.00-459.00-165.00-202.00-298.00-100.00-242.00
Cash from Financing Activity -3.00375.00-21.0090.0095.003.00302.00
Net Cash Flow -30.008.0062.00-18.0025.00-42.0038.00
Free Cash Flow -123.00-3.00177.00-9.00200.0027.00-53.00
CFO/OP % 35.00101.00-225.0051.00-65.00226.0062.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Debtor Days 59.0057.0059.0073.0095.0092.0088.0085.0074.00
Inventory Days 101.0092.0068.0091.0085.0067.0096.0093.00123.00
Days Payable 89.00100.0069.0082.00120.0063.0085.0060.0087.00
Cash Conversion Cycle 71.0049.0058.0082.0061.0096.0099.00118.00110.00
Working Capital Days 67.0047.00-11.004.00-2.0089.00121.00103.00109.00
ROCE % 7.0016.00-15.0079.00-71.008.0010.0014.00β€”

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Promoters 75.26 75.26 75.26 75.26 75.26 75.26 75.26 75.26
FIIs 1.91 1.38 1.14 2.27 4.24 5.77 6.36 7.34
DIIs 13.44 14.36 14.41 9.28 8.85 7.39 6.99 7.53
Public 6.67 6.29 6.45 10.46 8.92 8.84 8.64 7.14
No. of Shareholders 70,289 72,589 76,869 75,365 69,424 69,366 68,410 57,531

Corporate Actions

2 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Dividend 03 Jul 2026 03 Jul 2026 β€” 2.00 NSE/BSE dividend mismatch: BSE/NSE=1.0; BSE/NSE=2.0
Dividend 03 Jul 2026 03 Jul 2026 β€” 1.00 NSE/BSE dividend mismatch: BSE/NSE=1.0; BSE/NSE=2.0

Announcements

5 filings